These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 22845665

  • 1. Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation.
    Yousif S, Chaves C, Potin S, Margaill I, Scherrmann JM, Declèves X.
    J Neurochem; 2012 Nov; 123(4):491-503. PubMed ID: 22845665
    [Abstract] [Full Text] [Related]

  • 2. Effect of Subchronic Intravenous Morphine Infusion and Naloxone-Precipitated Morphine Withdrawal on P-gp and Bcrp at the Rat Blood-Brain Barrier.
    Chaves C, Gómez-Zepeda D, Auvity S, Menet MC, Crété D, Labat L, Remião F, Cisternino S, Declèves X.
    J Pharm Sci; 2016 Jan; 105(1):350-8. PubMed ID: 26554626
    [Abstract] [Full Text] [Related]

  • 3. Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism.
    Zhu HJ, Liu GQ.
    Life Sci; 2004 Jul 30; 75(11):1313-22. PubMed ID: 15234189
    [Abstract] [Full Text] [Related]

  • 4. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
    Durmus S, Xu N, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH.
    Pharmacol Res; 2013 Oct 30; 76():9-16. PubMed ID: 23827160
    [Abstract] [Full Text] [Related]

  • 5. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
    Kodaira H, Kusuhara H, Fujita T, Ushiki J, Fuse E, Sugiyama Y.
    J Pharmacol Exp Ther; 2011 Dec 30; 339(3):935-44. PubMed ID: 21934030
    [Abstract] [Full Text] [Related]

  • 6. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
    Kodaira H, Kusuhara H, Ushiki J, Fuse E, Sugiyama Y.
    J Pharmacol Exp Ther; 2010 Jun 30; 333(3):788-96. PubMed ID: 20304939
    [Abstract] [Full Text] [Related]

  • 7. P-glycoprotein, breast cancer resistance protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during blood-brain barrier maturation: involvement of Wnt/β-catenin and endothelin-1 signaling.
    Harati R, Benech H, Villégier AS, Mabondzo A.
    Mol Pharm; 2013 May 06; 10(5):1566-80. PubMed ID: 22998451
    [Abstract] [Full Text] [Related]

  • 8. Effect of chronic exposure to morphine on the rat blood-brain barrier: focus on the P-glycoprotein.
    Yousif S, Saubaméa B, Cisternino S, Marie-Claire C, Dauchy S, Scherrmann JM, Declèves X.
    J Neurochem; 2008 Nov 06; 107(3):647-57. PubMed ID: 18761714
    [Abstract] [Full Text] [Related]

  • 9. P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib.
    Chen Y, Agarwal S, Shaik NM, Chen C, Yang Z, Elmquist WF.
    J Pharmacol Exp Ther; 2009 Sep 06; 330(3):956-63. PubMed ID: 19491323
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Brain penetration of WEB 2086 (Apafant) and dantrolene in Mdr1a (P-glycoprotein) and Bcrp knockout rats.
    Fuchs H, Kishimoto W, Gansser D, Tanswell P, Ishiguro N.
    Drug Metab Dispos; 2014 Oct 06; 42(10):1761-5. PubMed ID: 25053619
    [Abstract] [Full Text] [Related]

  • 13. [¹¹C]befloxatone brain kinetics is not influenced by Bcrp function at the blood-brain barrier: a PET study using Bcrp TGEM knockout rats.
    Hosten B, Boisgard R, Jacob A, Goutal S, Saubaméa B, Dollé F, Scherrmann JM, Cisternino S, Tournier N.
    Eur J Pharm Sci; 2013 Nov 20; 50(3-4):520-5. PubMed ID: 23981334
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats.
    Dazert P, Suofu Y, Grube M, Popa-Wagner A, Kroemer HK, Jedlitschky G, Kessler C.
    Neuroscience; 2006 Nov 03; 142(4):1071-9. PubMed ID: 16997484
    [Abstract] [Full Text] [Related]

  • 15. P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats.
    Reichel V, Burghard S, John I, Huber O.
    Brain Res; 2011 Jan 25; 1370():238-45. PubMed ID: 21075088
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid can be used as a surrogate to assess brain exposures of breast cancer resistance protein and P-glycoprotein substrates.
    Xiao G, Black C, Hetu G, Sands E, Wang J, Caputo R, Rohde E, Gan LS.
    Drug Metab Dispos; 2012 Apr 25; 40(4):779-87. PubMed ID: 22266779
    [Abstract] [Full Text] [Related]

  • 17. Development and Validation of an In-Cell Western for Quantifying P-Glycoprotein Expression in Human Brain Microvascular Endothelial (hCMEC/D3) Cells.
    McInerney MP, Pan Y, Short JL, Nicolazzo JA.
    J Pharm Sci; 2017 Sep 25; 106(9):2614-2624. PubMed ID: 28065764
    [Abstract] [Full Text] [Related]

  • 18. ATP binding cassette transporters in two distinct compartments of the skin contribute to transdermal absorption of a typical substrate.
    Hashimoto N, Nakamichi N, Uwafuji S, Yoshida K, Sugiura T, Tsuji A, Kato Y.
    J Control Release; 2013 Jan 10; 165(1):54-61. PubMed ID: 23089896
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.